309 related articles for article (PubMed ID: 20045007)
1. Synergistic effects of FGF-2 and PDGF-BB on angiogenesis and muscle regeneration in rabbit hindlimb ischemia model.
Li J; Wei Y; Liu K; Yuan C; Tang Y; Quan Q; Chen P; Wang W; Hu H; Yang L
Microvasc Res; 2010 Jul; 80(1):10-7. PubMed ID: 20045007
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of fragmin/protamine microparticles containing fibroblast growth factor-2 (F/P MPs/FGF-2) to induce collateral vessels in a rabbit model of hindlimb ischemia.
Horio T; Fujita M; Tanaka Y; Ishihara M; Kishimoto S; Nakamura S; Hase K; Maehara T
J Vasc Surg; 2011 Sep; 54(3):791-8. PubMed ID: 21620612
[TBL] [Abstract][Full Text] [Related]
3. Dual gene transfer of fibroblast growth factor-2 and platelet derived growth factor-BB using plasmid deoxyribonucleic acid promotes effective angiogenesis and arteriogenesis in a rodent model of hindlimb ischemia.
de Paula EV; Flores-Nascimento MC; Arruda VR; Garcia RA; Ramos CD; Guillaumon AT; Annichino-Bizzacchi JM
Transl Res; 2009 May; 153(5):232-9. PubMed ID: 19375684
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2.
Cao R; Bråkenhielm E; Pawliuk R; Wariaro D; Post MJ; Wahlberg E; Leboulch P; Cao Y
Nat Med; 2003 May; 9(5):604-13. PubMed ID: 12669032
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
6. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor.
Kondoh K; Koyama H; Miyata T; Takato T; Hamada H; Shigematsu H
Cardiovasc Res; 2004 Jan; 61(1):132-42. PubMed ID: 14732210
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic site selection is important for the successful development of collateral vessels.
Nishiyama A; Koyama H; Miyata T; Watanabe T
J Vasc Surg; 2015 Jul; 62(1):190-9. PubMed ID: 24630870
[TBL] [Abstract][Full Text] [Related]
8. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
[TBL] [Abstract][Full Text] [Related]
9. VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.
Onimaru M; Yonemitsu Y; Fujii T; Tanii M; Nakano T; Nakagawa K; Kohno R; Hasegawa M; Nishikawa S; Sueishi K
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1685-96. PubMed ID: 19734356
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model.
Rissanen TT; Markkanen JE; Arve K; Rutanen J; Kettunen MI; Vajanto I; Jauhiainen S; Cashion L; Gruchala M; Närvänen O; Taipale P; Kauppinen RA; Rubanyi GM; Ylä-Herttuala S
FASEB J; 2003 Jan; 17(1):100-2. PubMed ID: 12475908
[TBL] [Abstract][Full Text] [Related]
11. Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia.
Wafai R; Tudor EM; Angus JA; Wright CE
J Vasc Res; 2009; 46(1):45-54. PubMed ID: 18552506
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor C promotes revascularization in ischemic limbs of diabetic mice.
Moriya J; Wu X; Zavala-Solorio J; Ross J; Liang XH; Ferrara N
J Vasc Surg; 2014 May; 59(5):1402-9.e1-4. PubMed ID: 23856609
[TBL] [Abstract][Full Text] [Related]
13. Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies.
Jean M; Smaoui F; Lavertu M; Méthot S; Bouhdoud L; Buschmann MD; Merzouki A
Gene Ther; 2009 Sep; 16(9):1097-110. PubMed ID: 19440230
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB.
Banfi A; von Degenfeld G; Gianni-Barrera R; Reginato S; Merchant MJ; McDonald DM; Blau HM
FASEB J; 2012 Jun; 26(6):2486-97. PubMed ID: 22391130
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia.
Takagi Y; Omura T; Yoshiyama M; Matsumoto R; Enomoto S; Kusuyama T; Nishiya D; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
J Pharmacol Sci; 2005 Sep; 99(1):45-51. PubMed ID: 16127245
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model.
Witzenbichler B; Mahfoudi A; Soubrier F; Le Roux A; Branellec D; Schultheiss HP; Isner JM
J Mol Med (Berl); 2006 Jun; 84(6):491-502. PubMed ID: 16389546
[TBL] [Abstract][Full Text] [Related]
18. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors.
Tanii M; Yonemitsu Y; Fujii T; Shikada Y; Kohno R; Onimaru M; Okano S; Inoue M; Hasegawa M; Onohara T; Maehara Y; Sueishi K
Circ Res; 2006 Jan; 98(1):55-62. PubMed ID: 16306442
[TBL] [Abstract][Full Text] [Related]
19. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
Qi X; Yuan Y; Xu K; Zhong H; Zhang Z; Zhai H; Guan G; Yu G
PLoS One; 2015; 10(5):e0125323. PubMed ID: 25944736
[TBL] [Abstract][Full Text] [Related]
20. NGF promotes hemodynamic recovery in a rabbit hindlimb ischemic model through trkA- and VEGFR2-dependent pathways.
Karatzas A; Katsanos K; Lilis I; Papadaki H; Kitrou P; Lecht S; Marcinkiewicz C; Siablis D; Lelkes PI; Lazarovici P; Tsopanoglou NE
J Cardiovasc Pharmacol; 2013 Sep; 62(3):270-7. PubMed ID: 23644989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
